Finvest
HCA Healthcare Services · Hospitals · ACA exposure · Medicaid payments · Thesis updated June 11, 2026

Payment cushion hides a volume question

01 Running thesis

Guidance held, mix got messier

HCA is still a large, scaled hospital operator with steady demand for care. In 2025, revenue rose 7.1% to $75.6 billion. Equivalent admissions rose 2.9%, and revenue per equivalent admission rose 4.0%. That shows the core system can still grow when patient volume and pricing both help.

Q1 2026 made the story harder to read. A mild respiratory season and winter storms hurt volume and created about a $180 million EBITDA drag. At the same time, state supplemental payment programs helped more than expected. Management now expects those programs to decline by only $50 million to $250 million for the full year, better than the prior expected decline of $250 million to $450 million.

The bull case is that this payment cushion gives HCA enough room to handle ACA exchange pressure, soft flu-related volume, and normal cost bumps while still meeting guidance. High-acuity care, such as cardiac, trauma, transplant, and neonatal services, can also lift revenue per case because these services are complex and usually paid at higher rates.

The bear case is that the cushion may be hiding weaker demand. Same-facility outpatient surgery fell 1.7% in Q1 2026, while inpatient surgery fell 0.3%. If ACA exchange volumes fall more than the planned 15% to 20% range, or if HCA's $400 million resiliency savings do not show up, the company could miss guidance even with help from state payments.

Apr 2026The Q1 2026 Form 10-Q confirmed the main call takeaways. Surgery volumes were weak, uninsured admissions rose, and risk factors had no material change.
Apr 2026Q1 guidance held, but the mix changed. Better state supplemental payments offset a mild respiratory season, storms, and the expected ACA exchange hit.
Feb 2026The 2025 Form 10-K confirmed strong 2025 growth and the key 2026 risks. It also showed Medicaid state directed and supplemental payment revenue rose to about $6.2 billion in 2025.
Jan 2026Initial 2026 guidance set clear headwinds: $600 million to $900 million from ACA exchanges and a $250 million to $450 million decline in state supplemental payment benefits. Management also set a $400 million resiliency savings target.
Oct 2025The Q3 2025 Form 10-Q confirmed the stronger Q3 view and did not add new material risk factors. The main forward risk stayed the possible ACA subsidy expiration.
Oct 2025Q3 2025 was stronger than expected, and HCA raised adjusted EBITDA guidance by $450 million at the midpoint. Surgery volumes also returned to growth in the quarter.
Jul 2025Q2 2025 results improved after Tennessee's state directed payment program was approved. Full-year 2025 guidance moved higher, though management trimmed volume growth expectations.
02 Business model

Hospitals with local scale

HCA makes money by treating patients in hospitals, emergency rooms, surgery centers, and other outpatient sites. Patients pay through commercial insurance, Medicare, Medicaid, ACA exchange plans, or self-pay. The company does not collect full list prices in most cases. It gets paid based on contracts, government rules, and patient ability to pay.

The strategy is to build deep networks in attractive markets. HCA adds beds, outpatient sites, doctors, and high-acuity programs so a patient can stay inside the HCA system for many needs. Scale matters because HCA can spread technology, staffing systems, purchasing, billing, and clinical processes across many facilities.

The model breaks when payer mix worsens. If more patients move from ACA exchange plans to uninsured status, HCA may still treat them but collect less cash. That risk is now showing up: same-facility uninsured equivalent admissions rose about 16% in Q1 2026, and management said more than half of that increase came from exchange shifts.

Capital needs are also large. HCA planned 2026 capital spending of $5.0 billion to $5.5 billion, and it had $46.492 billion of debt at the end of 2025. That does not make the model broken, but it means weak earnings or higher rates can matter faster.

03 Product portfolio

Care lines that drive the system

Cash cow

Inpatient hospital care

This is the core of HCA. Admissions, bed use, and case mix drive a large part of revenue and profit.

Steady

Emergency rooms

ERs bring patients into the network and often feed admissions. Same-facility ER visits rose only 0.3% in Q1 2026 after a mild respiratory season.

Option

Outpatient surgery

Outpatient care is important because more procedures keep moving outside the hospital. The problem is current softness, with same-facility outpatient surgery down 1.7% in Q1 2026.

Growth engine

High-acuity services

Cardiac, trauma, transplant, and neonatal programs help HCA treat harder cases. These services can raise case mix, which means more revenue per patient.

Steady

Medicaid supplemental payment programs

These programs are not a medical service, but they are a major payment source. HCA recorded about $6.2 billion of revenue from Medicaid state directed and supplemental payment programs in 2025.

04 Business segments

One system, two revenue settings

Inpatient and admitted care patient revenue62%modest
Outpatient patient revenue38%flat

HCA reports as one hospital system, not as many business segments. The mix below uses 2025 patient revenue setting from the 2025 Form 10-K: outpatient revenue was 38% of patient revenue, so inpatient and related admitted care was the balance.

05 Risk factors

What could break the thesis

ACA exchange drop gets worse

High impact · Medium odds

The ACA exchange headwind is already visible. HCA said same-facility exchange equivalent adjusted admissions fell about 15% in Q1 2026, with about a $150 million adjusted EBITDA hit. Full-year guidance assumes a $600 million to $900 million adverse EBITDA impact from exchange changes.

We watchSame-facility exchange equivalent admissions versus the guided 15% to 20% decline range.

Uninsured mix keeps rising

High impact · Medium odds

HCA treats many patients even when they cannot pay much. Same-facility uninsured equivalent admissions rose about 16% in Q1 2026. More than half of that increase came from people shifting away from exchange coverage, according to management.

We watchSame-facility uninsured admissions and total uncompensated care cost.

State payment help fades

High impact · Medium odds

Medicaid state directed and supplemental payments are a major part of the story. Revenue from these programs was about $6.2 billion in 2025. The 2026 outlook improved after favorable approvals in Georgia and Texas, but the programs remain political and subject to CMS review.

We watchCMS decisions on state directed payment programs, especially the Florida program not included in updated guidance.

Surgery weakness is not temporary

Medium impact · Medium odds

Surgery is a clear watch item because it can carry strong economics. Same-facility outpatient surgery fell 1.7% in Q1 2026, and inpatient surgery fell 0.3%. If this continues after the weak respiratory season noise fades, the core growth picture is softer than guidance suggests.

We watchQ2 and Q3 same-facility inpatient and outpatient surgery growth.

Debt and labor limit flexibility

Medium impact · Medium odds

HCA had $46.492 billion of debt at the end of 2025 and interest expense of $2.248 billion for the year. Labor is also the largest cost line, with salaries and benefits at 43.5% of 2025 revenue. Stable labor helps, but wage pressure or higher interest costs would reduce room for error.

We watchSalaries and benefits as a percent of revenue, interest expense, and total debt.
06 Quick answers

In one breath

How does HCA Healthcare make money?

HCA gets paid for hospital care, emergency visits, surgery, and outpatient services. Payment comes from commercial insurance, Medicare, Medicaid, ACA exchange plans, and patients who pay on their own.

Why are ACA exchanges important for HCA?

Exchange plans cover patients who might otherwise be uninsured. In Q1 2026, HCA said exchange equivalent admissions fell about 15%, and the EBITDA impact was about $150 million.

What is the biggest upside catalyst for HCA?

A favorable Florida supplemental payment decision could be important because management said it is not included in updated guidance. Stabilizing outpatient surgery would also help the market trust the core volume story.

Is HCA a low-risk healthcare stock?

No. HCA has scale and strong market positions, but it also has high exposure to government payment rules, uninsured volume, labor costs, and debt.